Montreal, 1 May 2019
Annually, there is an agreed process for reviewing content and structural changes to the List of Prohibited Substances and Methods (Prohibited List), which is an International Standard under Article 4.1 of the World Anti-Doping Code (Code).
As part of this process, stakeholder feedback is collected throughout the year; and then, in April of every year, WADA’s List Expert Group meets to discuss the feedback, evidence and proposed content and/or structural changes, and to formulate the draft Prohibited List.
On 11 and 12 April, the List Expert Group held a meeting that resulted in the following documents, which we are confidentially giving you access to today for Stakeholder Consultation, via WADAConnect, the Agency’s online stakeholder consultation platform:
Draft 2020 Prohibited List
Summary of Modifications, which is intended to facilitate your review
2020 Monitoring Program
As is customary, WADA kindly asks that someone within your organization, with the relevant professional experience and expertise in anti-doping, be given the opportunity to carefully review the draft 2020 Prohibited List and provide comments concerning the proposed content (additions, subtractions or other modifications) and/or structural changes. We would ask that, whenever possible, your comments be supported by relevant reference(s) to medical or scientific evidence; pharmacological effect; and/or, personal experience concerning the substances or methods in question.
Also, as was done last year, the WADAConnect platform will encourage you, separately, to propose further additions, subtractions or other modifications under ‘Comments for future consideration’; which will be evaluated and considered carefully over the course of the year but will not likely be incorporated within the 2020 Prohibited List.
To provide comments
Simply connect to WADAConnect. If you do not currently have access, please consult the short guide on how to create a user account that is available on the platform.
Once you have a user account, please inform email@example.com and ask to be added to the private List Consultation Group. This is necessary in order to provide comments.
Please input your comments by 12 July 2019.
We believe that conducting this Stakeholder Consultation helps ensure that the Prohibited List evolves in step with the highest possible scientific standards; and, reflects the needs of the anti-doping community.
In keeping with the annual process, the 2020 Prohibited List will not be made public until 1 October 2019. Therefore, we would ask you to ensure that the draft is kept confidential in order to preserve the integrity of the Stakeholder Consultation process. As we know, earlier publication would compromise the process and lead to confusion in the minds of athletes and other stakeholders worldwide.
Should you have any questions or concerns, please contact firstname.lastname@example.org.
Thank you in advance for your organization’s feedback.
World Anti-Doping Agency
The World Anti-Doping Agency (WADA) is pleased to announce the appointment of Amanda Hudson as WADA’s new Director of Education, effective 5 August 2019.
Ms. Hudson, who is currently Head of Education for UK Anti-Doping in London, will lead the development and implementation of WADA’s education strategy, programs and activities, including managing WADA’s Social Science Research Grant Program and the Agency’s Education Committee.
In October 2018, Director of Communications, Catherine MacLean, assumed leadership of the education portfolio and set out to recruit a Deputy Director of Education to help develop and drive WADA’s education strategy. Due to the quality of the applications received during the recruitment phase, management decided to upgrade the role to Director, carving education out as a stand-alone department with a seat at the management table. This optimized structure reflects the increasing importance with which WADA and its stakeholders view the areas of both education and communications to the Agency and the global anti-doping program.
WADA Director General Olivier Niggli said: “I am delighted that Amanda will be joining WADA to take on this important mandate as the Director of Education. With almost 15 years connected to sport, nine of which with UKAD, Amanda brings with her a wealth of experience in developing and delivering excellent anti-doping education programs. Her strategic approach and leadership are exactly what we need to bring this core business activity to the next level.
“WADA’s success depends on its 100+ team of committed and skilled individuals. This appointment will reinforce WADA’s Management Team and will help the Agency deliver on its mission for athletes and other stakeholders in 2019 and beyond.”
Amanda Hudson will be located at WADA’s head office in Montreal, Canada. Until Ms. Hudson’s arrival in August, Ms. MacLean will maintain leadership of Education in addition to Communications.
Montreal, 30 April 2019 – Since January’s retrieval by the World Anti-Doping Agency (WADA) of the analytical data generated by the former Moscow Laboratory in Russia, WADA Intelligence and Investigations (I&I) has been working on a mission to extract all relevant samples still contained within the laboratory.
WADA can confirm that a five-person team has successfully retrieved 2,262 samples from the laboratory, which had been split into A and B samples and contained within 4,524 collection bottles. The samples have now been taken out of Moscow and are on their way to a WADA-accredited laboratory outside of Russia. Importantly, all samples targeted by I&I in advance of the mission were successfully located and extracted.
WADA Director of I&I Gunter Younger, who is leading the process, said: “WADA Intelligence and Investigations is pleased to be continuing to make progress in this complex and difficult case. Extracting the required samples from the laboratory is another step forward. These samples will be used to strengthen cases against those who may have cheated and may exonerate athletes who have not committed an anti-doping rule violation.”
“In removing the bottles, as a precaution we decided to take any and all samples that corresponded to data in the Laboratory Information Management System (LIMS) database that was even remotely anomalous, even where an anti-doping rule violation (ADRV) was not suspected. We can therefore proceed to the next phase and support the various International Federations (IFs) and other Anti-Doping Organizations to bring cases forward.”
In parallel, the authentication process of the Moscow data is close to completion. In early May, a progress report from that process will be sent to the independent Compliance Review Committee – which has received updates from WADA I&I every two weeks since the data was extracted in January – and an update will be presented at the next meetings of WADA’s Executive Committee and Foundation Board on 15 and 16 May, respectively.
Meanwhile, the process continues as I&I investigators identify all available evidence for each case, including ordering further sample analysis, where appropriate. In due course, the relevant IFs will be presented with evidentiary packages, which they will assess with the view to taking the cases forward as ADRVs. In cases where IFs choose not to take action, WADA will review the facts, discuss with the relevant IF and reserves the right to bring them forward to the Court of Arbitration for Sport.
Last week, WADA held a conference call with a number of IFs outlining the next steps and answering any questions they might have. Similar conference calls have also been held with athletes and with National Anti-Doping Organizations (NADOs).
Background: The successful data and sample retrieval came about as a result of the 20 September 2018 decision of WADA’s Executive Committee to reinstate the Russian Anti-Doping Agency (RUSADA), under strict conditions, to the list of World Anti-Doping Code-compliant Signatories. Under the terms of that decision, the Russian authorities were required to provide the data while also agreeing that any samples required by WADA for re-analysis would be made available by 30 June 2019. The samples had been stored and sealed off as part of a federal investigation being carried out by Russian authorities.
Further information: WADA has produced a flowchart that summarizes the three phases of the RUSADA Compliance Process and has compiled a document that summarizes the ‘Progress of the Anti-Doping System in Light of the Russian Doping Crisis’.
Montreal, 29 April 2019
The World Anti-Doping Agency (WADA) is pleased to launch a series of Therapeutic Use Exemption (TUE) Checklists to provide guidance and support to athletes, their physicians and Anti-Doping Organizations (ADOs) during the TUE application process.
These new Checklists are based on the TUE Committee Guidelines (TUEC Guidelines) (Medical Information to Support the Decisions of TUECs documents); which were developed by WADA and external medical specialists primarily for TUECs. The Checklists – which cover the most commonly seen conditions – list the requirements for completing the TUE Application Form, including the medical evidence that must be submitted along with it.
Following a successful pilot project with a number of National Anti-Doping Organizations and International Federations over the last few months, we now invite all ADOs to use the Checklists in their interactions with athletes and applying physicians. We also invite stakeholders to adapt the official English versions by translating and customizing them as necessary – while ensuring that the key elements remain.
ADOs interested in making their translations available on WADA’s website are strongly encouraged to do so and to send their translations to email@example.com by 17 May 2019. We will be posting all TUE checklists on the WADA website after this date.
We thank you in advance for your efforts and collaboration in adopting these Checklists. Should you have any questions or wish to provide feedback, please contact firstname.lastname@example.org.
Craig Carscadden, Chief Executive of CPISRA, is currently in São Paulo at the World Para Athletics Grand Prix where, excitingly, RaceRunning was included for the first time.
Yesterday, Craig gave a RaceRunning Awareness and Coaching presentation to coaches, team managers and athletes from Honduras, Costa Rica, Peru, Paraguay, Colombia and Brazil.
Big thanks to the national member of CPISRA for Brazil ANDE - Associação Nacional de Desporto para Deficientes and the competition hosts Comitê Paralímpico Brasileiro - CPB for your warm welcome and for facilitating this presentation.
Montreal, 24 April 2019 – A newly developed method for detecting the use of prohibited substances in athletes has led to a significant and unprecedented 29 March 2019 decision by the Court of Arbitration for Sport (CAS) in favour of the World Anti-Doping Agency (WADA).
CAS issued a final award confirming Anti-Doping Rule Violations (ADRVs) in the cases of the Ukrainian track and field athletes, Olesia Povh and Olha Zemliak. Both athletes were convicted of using a prohibited substance based on the detection of non-physiological levels of testosterone in their blood serum samples following analysis in the WADA-accredited laboratories in Lausanne, Switzerland, and Seibersdorf, Austria.
The testing was initiated by the Athletics Integrity Unit (AIU) of the International Association of Athletics Federations (IAAF). This led to the subsequent investigation, which resulted in these important convictions. The measurement of testosterone levels in blood serum constitutes a further tool for Anti-Doping Organizations (ADOs) to detect and prosecute doping, even where urine samples might be reported as negative.
WADA Director General Olivier Niggli said: “WADA welcomes this decision by CAS, which could have a long-term positive impact on clean sport. I would also like to commend the AIU for their excellent work which led to this outcome. The decision sets an important precedent and this new method of detecting doping represents another way for ADOs to secure Anti-Doping Rule Violations against those who choose to cheat. It is a significant victory for clean sport and for athletes around the world.”
Significantly, CAS ruled that there could be no doubt on the evidence that the method used in measuring testosterone in blood serum was scientifically valid, paving the way for further examples of this method being used in the future.
Olesia Povh was sanctioned with a four-year period of ineligibility for intentional doping while Olha Zemliak received an eight-year period of ineligibility as it was her second violation.
Introduction to Classification
What is classification?
Classification is defined as “grouping athletes into sport classes according to how much their impairment affects fundamental activities in each specific sport and discipline” (November 2015 IPC Athlete Classification Code, art. 2.1).
What is it purpose of classification?
Classification provides a structure for competition. Athletes competing in Para sports have an impairment that leads to a competitive disadvantage. Consequently, a system has to be put in place to minimise the impact of impairments on sport performance and to ensure the success of an athlete is determined by skill, fitness, power, endurance, tactical ability and mental focus. This system is called classification.
Is there one classification system for all sports?
No, each International Sports Federation or Para Sport must have and publish their own classification system. For example, the classification system and classes for swimming will be different for those in athletics, boccia or sailing. This is because each sport is different and, therefore, the effect of the impairment on each sport will be different.
How is it performed?
Will I be classified more than once?
At international level, an athlete will normally receive a confirmed classification after their first competition. The exceptions to this are where athletes may not have reached physical maturity or they are new to the sports and lack technical maturity in the sport.
Athletes who have a progressive condition will never receive a confirmed classification because their condition may change. These athletes may be seen by a classification panel at every international competition or they may be given a fixed review which means they will be seen by a panel at a fixed date in the future e.g. every two years.
If an athlete’s medical condition changes or they have undergone a medical procedure or operation, they can request to be re-classified if they feel their ability to perform in their sport has changed.
How do I get classified?
The best way of getting classified is to approach your national disability sport organisation, your national Paralympic Committee or the national governing body which governs your Para Sport. They will advise you on the best way forward.
I want to be a classifier, how can I become one?
To be a classifier, you need a medical background or have a technical knowledge of the specific sport or sport science. If you have such qualifications and want to get involved you should contact your National Paralympic Committee or National Governing body for the sport you are interested in. If you have any problems finding the appropriate pathway, you contact us at email@example.com.
Where can I find further information?
Further detail on the (complex) matter of classification in the Paralympic Movement is available from the IPC website: https://www.paralympic.org/classification.